Autoimmune diseases: MIF as a therapeutic target

被引：68
作者：
Greven, Dorothee [1 ]
Leng, Lin [2 ]
Bucala, Richard [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands
[2] Yale Univ, Rheumatol Sect, New Haven, CT 06510 USA
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2010年 / 14卷 / 03期
关键词：
MIGRATION-INHIBITORY FACTOR; JUVENILE IDIOPATHIC ARTHRITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; FACTOR GENE POLYMORPHISM; INNATE IMMUNE-RESPONSES; RHEUMATOID-ARTHRITIS; REGULATORY ROLE; PROINFLAMMATORY FUNCTION; PROMOTER POLYMORPHISMS; CRYSTAL-STRUCTURE;
D O I：
10.1517/14728220903551304
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Areas covered in this review: Our aim is to discuss MIF-directed therapies as a novel therapeutic approach. The review covers literature from the past 10 years. What the reader will gain: MIF inhibition has been shown to be efficacious in many experimental and pre-clinical studies of autoimmune inflammatory diseases. The close regulatory relationship between MIF and glucocorticoids makes therapeutic antagonism of MIF a potential steroid-sparing therapy in patients with refractory autoimmune diseases. Take home message: We expect that MIF antagonism by either small-molecule- or antibody-based approaches will find wide application in the treatment of autoimmune inflammatory diseases. Such therapy also may be informed by the MIF genotype of affected patients.
引用
收藏
页码：253 / 264
页数：12
相关论文
共 50 条
  • [31] Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases
    Kameda, Hideto
    Suzuki, Miyuki
    Takeuchi, Tsutomu
    DRUG TARGET INSIGHTS, 2007, 2 : 239 - 247
  • [32] The Role of MIF-173G/C Gene Polymorphism in the Susceptibility of Autoimmune Diseases
    Du, Xiangrong
    Li, Ruixia
    Song, Shoujun
    Ma, Lei
    Xue, Haibo
    MEDIATORS OF INFLAMMATION, 2020, 2020
  • [33] MIF as a disease target: ISO-I as a proof-of-concept therapeutic
    Al-Abed, Yousef
    VanPatten, Sonya
    FUTURE MEDICINAL CHEMISTRY, 2011, 3 (01) : 45 - 63
  • [34] Inflammatory molecules: A target for treatment of systemic autoimmune diseases
    Tincani, A.
    Andreoli, L.
    Bazzani, C.
    Bosisio, D.
    Sozzani, S.
    AUTOIMMUNITY REVIEWS, 2007, 7 (01) : 1 - 7
  • [35] MIF, MIF Alleles, and Prospects for Therapeutic Intervention in Autoimmunity
    Bucala, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2013, 33 : S72 - S78
  • [36] Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications
    Murdaca, Giuseppe
    Tonacci, Alessandro
    Negrini, Simone
    Greco, Monica
    Borro, Matteo
    Puppo, Francesco
    Gangemi, Sebastiano
    AUTOIMMUNITY REVIEWS, 2019, 18 (09)
  • [37] Potential therapeutic applications of exosomes in different autoimmune diseases
    Xu, Hui
    Jia, Shaochang
    Xu, Hanmei
    CLINICAL IMMUNOLOGY, 2019, 205 : 116 - 124
  • [38] Pulmonary manifestations of autoimmune diseases and new therapeutic options
    Nagel, F.
    Burmester, H.
    Feilcke, M.
    Ripper, J.
    Pawlita, I.
    Hengst, M.
    Kappler, M.
    Griese, M.
    MONATSSCHRIFT KINDERHEILKUNDE, 2015, 163 (06) : 550 - +
  • [39] Pulmonary manifestations of autoimmune diseases and new therapeutic options
    Nagel, F.
    Burmester, H.
    Feilcke, M.
    Ripper, J.
    Pawlita, I.
    Hengst, M.
    Kappler, M.
    Griese, M.
    MONATSSCHRIFT KINDERHEILKUNDE, 2015, 163 (06) : 550 - +
  • [40] Engineered T cells and their therapeutic applications in autoimmune diseases
    Bao, Lei
    Bo, Xiao-Chen
    Cao, Huai-Wen
    Qian, Chen
    Wang, Zeng
    Li, Bin
    ZOOLOGICAL RESEARCH, 2022, 43 (02) : 150 - 165
12345